Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I

Journal of Lipid Research

Volumn 40, Issue 4, 1999, Pages 654-664

  Jauhiainen, M ^a   Huuskonen, J ^a   Baumann, M ^b   Metso, J ^a   Oka, T ^c   Egashira, T ^c   Hattori, H ^c   Olkkonen, V M ^a   Ehnholm, C ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c R and D Center   (Japan)

Author keywords

Apolipoprotein A I; HDL metabolism; Phospholipid transfer protein; Proteolytic activity

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CORONARY RISK; ENZYME ACTIVITY; HUMAN; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; BACULOVIRIDAE; CARRIER PROTEINS; CHO CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; HUMANS; INSECTS; LIPOPROTEINS, HDL; MASS SPECTROMETRY; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PARTICLE SIZE; PEPTIDE FRAGMENTS; PHOSPHOLIPID TRANSFER PROTEINS; PROTEASE INHIBITORS; RECOMBINANT PROTEINS;

EID: 0032957085     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Gordon, D. J., and B. M. Rifkind. 1989. High density lipoprotein -the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
2. Rubin, E. M., B. Y. Ishida, S. M. Clift, and R. M. Krauss. 1991. Expression of humanapolipoprotcin A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA. 88: 434-438.
3. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the antiatherogenic properties of HDL in transgenic mice. Nature. 365: 762-764.
4. Tall, A. R. 1990. Plasma high density lipoproteins, metabolism, and relationship to atherosclerosis. J. Clin. Invest. 86: 379-384.
5. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
6. Huang, Y., A. von Eckardstein, S. Wu, and G. Assmann. 1995. Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler. Thromb. Vasc. Biol. 15: 1412-1418.
7. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
8. Tu, A-Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
9. Albers, J. J., G. Wolfbauer, M. C. Cheung, J. R. Day, A. F. T. Ching, and A-Y. Tu. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
10. Pussinen, P., M. Jauhiainen, J. Metso, J. Tyynelä, and C. Ehnholm. 1995. Pig plasma phospholipid transfer protein facilities HDL interconversion. J. Lipid Res. 36: 975-985.
11. Lagrost, L., A. Athias, B. Herbeth, V. Guyard-Dangremont, Y. Artur, F. Paille, P. Gambert, and C. Lallemant. 1996. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. J Biol. Chem. 271: 19058-19065.
12. Lusa, S., M. Jauhiainen, J. Metso, P. Somerharju, and C. Ehnholm. 1996. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem. J. 313: 275-282.
13. von Eckardstein, A., M. Jauhiainen, Y. Huang, J. Metso, C. Langer, P. Pussinen, S. Wu, C. Ehnholm, and G. Assmann. 1996. Phospholipid transfer protein-mediated conversion of high density lipoprotein generates preβ1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
14. Kunitake, S. T., K. J. LaSala, and J. P. Kane. 1985. Apolipoprotein A-I-containing lipoprotcins with pre-beta electrophoretic mobility. J. Lipid Res. 26: 549-555.
15. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
16. Kunitake, S. T., G. Chi Chen, S-F. Kung, J. W. Schilling, D. A. Hardman, and J. P. Kane. 1990. Pre-beta high density lipoprotein. Unique disposition of apolipoprotein A-I increases susceptibility to proteolysis. Arteriosclerosis. 10: 25-30.
17. Dalton, M. B., and J. B. Swaney. 1993. Structural and functional domain of apolipoprotein A-I within high density lipoproteins. J. Biol. Chem. 268: 19274-19283.
18. Havel, R. J., H. A. Eder, and J. R. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
19. Scanu, A. 1966. Forms of human serum high density lipoprotein protein. J. Lipid Res. 7: 295-306.
20. Scanu, A., and G. Edelstein. 1971. Solubility in aqueous solutions of ethanol of small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during dclipidation of serum lipoproteins. Anal. Biochem. 44: 576-588.
21. Scanu, A. M., G. T. Lim, and G. Edelstein. 1972. On the subunit structure of the protein of human serum high density lipoprotein. J. Biol. Chem. 247: 5850-5855.
22. Marques-Vidal, P., M. Jauhiainen, J. Metso, and G. Ehnholm. 1997. Transformation of high density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein. Atherosclerosis. 133: 87-95.
23. 3 in vitro and its effect on PLTP-mediated phospholipid transfer. Biochim. Biophys. Acta. 1391: 181-192.
24. Sarcich, J. L., H. D. Fischer, M. S. Babcock, J. W. Leone, and A. G. Tomasselli. 1995. Expression and purification of recombinant cynomolgus monkey cholesteryl ester transfer protein from Chinese hamster ovary cells. J. Protein Chem. 14: 73-80.
25. Day, J. R., J. J. Albers, G. E. Lofton-Day, T. L. Gilbert, A. F. T. Ching, F. J. Grant, P. J. O'Hara, S. M. Marcovina, and J. L. Adolphson. 1994. Complete cDNA encoding human phospholipid transfer protein from human endothclial cells. J. Biol. Chem. 269: 9388-9391.
26. Kim, D. W., T. Uetsuki, Y. Kaziro, N. Yamaguchi, and S. Sugano. 1990. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene. 91: 217-223.
27. Feigner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wez, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84: 7413-7417.
28. Lerch, P. G., J-J. Morgenthaler, M. C. Peitsch, H. Friedli, G. Hodler, J. E. Doran, H. Isliker, and H-J. Heiniger. 1989. Isolation and properties of apolipoprotein A for therapeutic use. Prot. Biol. Fluids. 36: 409-416.
29. Blanche, P. J., E. L. Gong, T. M. Forte, and A. V. Nichols. 1981. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665: 408-419.
30. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
31. Riepponen, P., J. Marniemi, and T. Rautaoja. 1987. Immunoturbidimetric assays of apolipoproteins A-I and B in serum. Scand. J. Clin. Invest. 47: 739-745.
32. Bergmeyer, H. U. 1985. Metabolites 3: lipids, amino acids and related compounds. In Methods of Enzymatic Analysis. Vol. VIII. J. Bergmeyer and M. Grassl, editors. VCH Weinheim, Germany. 1-160.
33. Groener, J. E. M., R. W. Pelton, and G. M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32: 283-286.
34. Jauhiainen, M., and P. J. Dolphin. 1986. Human plasma lecithin-cholesterol acyltransferace: an elucidation of catalytic mechanism. J. Biol. Chem. 261: 7032-7043.
35. Laemmli, U. K. 1979. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
36. Towbin, H., T. Staehlin, and J. Gordon. 1979. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Prof. Natl. Acad. Sci. USA. 76: 4350-4357.
37. Pussinen, P. J., M. Jauhiainen, and C. Ehnholm. 1997. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. J. Lipid Res. 38: 12-21.
38. Davidson, W. S., D. L. Sparks, S. Lund-Katz, and M. C. Phillips. 1994. The molecular basis for the difference in charge between preβ-and α-migrating high density lipoproteins. J. Biol. Chem. 269: 8959-8965.
39. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-β HDL: structure and metabolism. Biochim. Biophys. Acta. 1300: 73-85.
40. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94: 12291-12296.
41. Ji, Y., and A. Jonas. 1995. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins. J. Biol. Chem. 270: 11290-11297.
42. Minnich, A., X. Collet, A. Roghani, C. Cladaras, R. L. Hamilton, C. J. Fielding, and V. I. Zannis. 1992. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. J. Biol. Chem. 267: 16553-16560.
43. Laccotripe, M., S. C. Makrides, A. Jonas, and V. I. Zannis. 1997. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein. J. Biol. Chem. 272: 17511-17522.
44. Rogers, D. P., C. G. Brouillette, J. A. Engler, S. W. Tendian, L. Roberts, V. K. Mishra, G. M. Anantharamaiah, S. Lund-Katz, M. C. Phillips, and M. J. Ray. 1997. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36: 288-300.
45. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apoA-I and apoA-II fractional catabolic rate in patients with low high density lipoprotein cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.
46. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1994. Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler. Thromb. 14: 707-720.
47. Glass, C. K., P. C. Pittman, G. A. Keller, and D. Steinberg. 1983. Tissue sites of degradation of apoprotein A-I in the rat. J. Biol. Chem. 258: 7161-7167.
48. Goldberg, I. J., W. S. Blaner, T. M. Vanni, M. Moukides, and R. Ramakrisnan. 1990. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J. Clin. Invest. 86: 463-473.
49. Liu, J. N., and V. Gurewich. 1993. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activators. Blood. 81:980-987.
50. Ponting, C. P., J. M. Marshall, and S. A. Cederholm-Williams. 1992. Plasminogen: a structural review. Blood Coagul. & Fibrinolysis. 3: 605-614.
51. Rieger, K. J., N. Saez-Servent, M. P. Papet, J. Wdzieczak-Bakala, J. L. Morgat, J. Thierry, W. Voelter, and M. Lenfant. 1993. Involvement of human plasma angiotensin 1-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem. J. 296: 373-378.
52. Lins, L., S. Piron, K. Conrath, B. Vanloo, R. Brasseur, M. Rosseneu, J. Baert, and J. M. Ruysschaert. 1993. Enzymatic hydrolysis of reconstituted dimyristoylphosphatidylcholine-apoA-I complexes. Biochim. Biophys. Acta. 1151: 137-142.
53. Schmidt, H. H. J., A. T. Remaley, J. A. Stonik, R. Ronan, A. Wellmann, F. Thomas, L. A. Zech, H. B. Brewer, Jr., and J. M. Hoeg. 1995. Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism. J. Biol. Chem. 270: 5469-5475.
54. Holvoet, P., S. Danloy, and D. Collen. 1997. Role of the carboxyterminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism. Eur. J. Biochem. 245: 642-647.
55. Föger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
56. Ehnholm, S., K. W. Van Dijk, B. van t'Hof, A. van der Zee, V. M. Olkkonen, M. Jauhiainen, M. Hofker, L. Havekes, and C. Ehnholm. 1998. Adenovirus-mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
57. Beamer, L. J., S. F. Carroll, and D. Eisenberg. 1997. Crystal structure of human BPI and two bound phospholipids at 2.4 ångstrōm resolution. Science. 276: 1861-1864.